Decreased Risk of Recurrent Acute Pancreatitis with Semaglutide and Tirzepatide in People with Type 2 Diabetes or Obesity with a History of Acute Pancreatitis: A Propensity Matched Global Federated TriNetX Database-Based Retrospective Cohort Study
Diabetes & Metabolic Syndrome Clinical Research & Reviews（2024）
Key words
Acute pancreatitis,GLP-1 receptor agonists,Semaglutide,Tirzepatide,recurrence risk,TriNetX,retrospective cohort study
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined